Evidence map›Paper›PMID 38324366›Full record

ArticleJMIR mHealth and uHealth2024

Effectiveness of Telemonitoring in Reducing Hospitalization and Associated Costs for Patients With Heart Failure in Finland: Nonrandomized Pre-Post Telemonitoring Study.

Jorma Kokkonen, Pirjo Mustonen, Eija Heikkilä, Riikka-Leena Leskelä, Paula Pennanen, Kati Krühn, Arto Jalkanen, Jussi-Pekka Laakso, Jari Kempers, Sami Väisänen and 1 more

Open access · goldAbstract read
In one paragraph

Article in JMIR mHealth and uHealth, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Jorma KokkonenTampere Heart Hospital, Tampere, Finland.ORCID 0009-0003-3833-7303
Pirjo MustonenThe Wellbeing Services County of Southwest Finland, Turku, Finland.ORCID 0000-0002-4299-0618
Eija HeikkiläNordic Healthcare Group, Helsinki, Finland.ORCID 0000-0002-3736-8410
Riikka-Leena LeskeläNordic Healthcare Group, Helsinki, Finland.ORCID 0000-0002-9255-2958
Paula PennanenNordic Healthcare Group, Helsinki, Finland.ORCID 0009-0001-2451-1097
Kati KrühnRoche Diagnostics (Schweiz) AG, Zug, Switzerland.ORCID 0009-0005-3661-5589
Arto JalkanenThe Wellbeing Services County of South Savo, Mikkeli, Finland.ORCID 0009-0006-9776-7954
Jussi-Pekka LaaksoCeneron Advisor Oy, Helsinki, Finland.ORCID 0000-0002-6019-7592
Jari KempersEuropean Health Economics Oy, Jyväskylä, Finland.ORCID 0009-0003-7651-4470
Sami VäisänenRoche Diagnostics Oy, Espoo, Finland.ORCID 0000-0001-8621-9406
Paulus TorkkiDepartment of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-1127-4205
Roche (Finland) · FIRoche (Switzerland) · CHTampere University Hospital · FIUniversity of Helsinki · FIVarsinais-Suomen Sairaanhoitopiiri · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany patients with chronic heart failure (HF) experience a reduced health status, leading to readmission after hospitalization despite receiving conventional care. Telemonitoring approaches aim to improve the early detection of HF decompensations and prevent readmissions. However, knowledge about the impact of telemonitoring on preventing readmissions and related costs remains scarce.

objectiveThis study assessed the effectiveness of adding a telemonitoring solution to the standard of care (SOC) for the prevention of hospitalization and related costs in patients with HF in Finland.

methodsWe performed a nonrandomized pre-post telemonitoring study to estimate health care costs and resource use during 6 months on SOC followed by 6 months on SOC with a novel telemonitoring solution. The telemonitoring solution consisted of a digital platform for patient-reported symptoms and daily weight and blood pressure measurements, automatically generated alerts triggering phone calls with secondary care nurses, and rapid response to alerts by treating physicians. Telemonitoring solution data were linked to patient register data on primary care, secondary care, and hospitalization. The patient register of the Southern Savonia Social and Health Care Authority (Essote) was used. Eligible patients had at least 1 hospital admission within the last 12 months and self-reported New York Heart Association class II-IV from the central hospital in the Southern Savonia region.

resultsOut of 50 recruited patients with HF, 43 completed the study and were included in the analysis. The hospitalization-related cost decreased (49%; P=.03) from €2189 (95% CI €1384-€2994; a currency exchange rate of EUR €1=US $1.10589 is applicable) during SOC to €1114 (95% CI €425-€1803) during telemonitoring. The number of patients with at least 1 hospitalization due to HF was reduced by 70% (P=.002) from 20 (47%) out of 43patients during SOC to 6 (14%) out of 43 patients in telemonitoring. The estimated mean total health care cost per patient was €3124 (95% CI €2212-€4036) during SOC and €2104 (95% CI €1313-€2895) during telemonitoring, resulting in a 33% reduction (P=.07) in costs with telemonitoring.

conclusionsThe results suggest that the telemonitoring solution can reduce hospital-related costs for patients with HF with a recent hospital admission.

Indexed as

Heart FailureHospitalizationFinlandHealth StatusHospitalsHumanscostFinlandheart failurehospitalresource usetelemonitoring

Identifiers

PMID38324366
PMCPMC10896481
OpenAlexW4389581563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.